Simon Krooss pipetting in the laboratory at a radioactive workstation equipped with Geiger counters. With the help of the radioactive markers, the expression of genes in the samples can be traced; Copyright: Karin Kaiser / MHH.
Simon Krooss pipetting in the laboratory at a radioactive workstation equipped with Geiger counters. With the help of the radioactive markers, the expression of genes in the samples can be traced; Copyright: Karin Kaiser / MHH. MHH junior scientist receives 60.000 euro prize for research on haemophilia A therapy Stand: 30. Haemophilia A is a hereditary blood clotting disorder. About 4.000 people in Germany are affected. The so-called clotting factor VIII (FVIII) is disturbed or missing completely. When injured, the blood then clots more slowly, which can lead to chronic joint damage or acutely life-threatening situations.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
